Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-26

FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for buspirone hydrochloride from Mylan Pharmaceuticals Inc., allowing a generic version of the anxiety medication to be …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone hydrochloride (buspirone hydrochloride)

Snippet

SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)